To test the apoptotic cell targeting of PSP1 and annexin V in vivo, we injected PSP1 or annexin V into tumor-bearing mice treated with the anticancer agent camptothecin, which acts primarily through induction of apoptosis. Here, ANXA5 is linked to neoplasm.